Drug Therapy, Other

Citations 51-60 of 113 total displayed.

Past content (since Sep 1999):

Observations
Steroid Treatment of Primary Progressive Aphasia

David A. Decker; Kenneth M. Heilman
Arch Neurol 2008; 65: 1533-1535. [Abstract] [Full text] [PDF]  

Original Contributions
Sodium Oxybate for Excessive Daytime Sleepiness in Parkinson Disease: An Open-Label Polysomnographic Study

William G. Ondo; Thomas Perkins; Todd Swick; Keith L. Hull Jr; J. Ernesto Jimenez; Tippy S. Garris; Daniel Pardi
Arch Neurol 2008; 65: 1337-1340. [Abstract] [Full text] [PDF]  

Original Contributions
Treatment of Neuromyelitis Optica With Rituximab: Retrospective Analysis of 25 Patients

Anu Jacob; Brian G. Weinshenker; Ivo Violich; Nancy McLinskey; Lauren Krupp; Robert J. Fox; Dean M. Wingerchuk; Mike Boggild; Cris S. Constantinescu; Aaron Miller; Tracy De Angelis; Marcelo Matiello; Bruce A. C. Cree
Arch Neurol 65.11.noc80069. [Abstract] [Full text] []  

Editorials
Bridging Anticoagulation After Cardioembolic Stroke

Robert J. Wityk
Arch Neurol 2008; 65: 1157. [Extract] [Full text] [PDF]  

Neurological Reviews
Monoclonal Antibody Therapies and Neurologic Disorders

John C. Novak; Amy E. Lovett-Racke; Michael K. Racke
Arch Neurol 2008; 65: 1162-1165. [Abstract] [Full text] [PDF]  

Original Contributions
Anticoagulation After Cardioembolic Stroke: To Bridge or Not to Bridge?

Hen Hallevi; Karen C. Albright; Sheryl Martin-Schild; Andrew D. Barreto; Sean I. Savitz; Miguel A. Escobar; Nicole R. Gonzales; Elizabeth A. Noser; Kachi Illoh; James C. Grotta
Arch Neurol 2008; 65: 1169-1173. [Abstract] [Full text] [PDF]  

Original Contributions
Aggressive Blood Pressure–Lowering Treatment Before Intravenous Tissue Plasminogen Activator Therapy in Acute Ischemic Stroke

Sheryl Martin-Schild; Hen Hallevi; Karen C. Albright; Aslam M. Khaja; Andrew D. Barreto; Nicole R. Gonzales; James C. Grotta; Sean I. Savitz
Arch Neurol 2008; 65: 1174-1178. [Abstract] [Full text] [PDF]  

Editorials
Thrombolysis, Fluctuations, Trials, and Such

Louis R. Caplan
Arch Neurol 2008; 65: 1017-1019. [Extract] [Full text] [PDF]  

Clinical Trials
Phase 2 Safety Trial Targeting Amyloid β Production With a -Secretase Inhibitor in Alzheimer Disease

Adam S. Fleisher; Rema Raman; Eric R. Siemers; Lida Becerra; Christopher M. Clark; Robert A. Dean; Martin R. Farlow; James E. Galvin; Elaine R. Peskind; Joseph F. Quinn; Abdullah Sherzai; B. Brooke Sowell; Paul S. Aisen; Leon J. Thal
Arch Neurol 2008; 65: 1031-1038. [Abstract] [Full text] [PDF]  

Original Contributions
Thrombolysis in Patients With Marked Clinical Fluctuations in Neurologic Status Due to Cerebral Ischemia

Ozcan Ozdemir; Vadim Beletsky; Richard Chan; Vladimir Hachinski
Arch Neurol 2008; 65: 1041-1043. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12